Bioregulator Peptides (Khavinson)

Bioregulator peptides are a class of short synthetic peptides, typically 2 to 4 amino acids in length, developed by Russian researcher Vladimir Khavinson based on sequences derived from organ-specific tissues. These peptides are theorized to exert tissue-specific regulatory effects by interacting with chromatin to modulate gene expression and restore age-related functional declines.

Examples include thymus-derived peptides (Thymalin), pineal peptides (Epithalamin), and vascular peptides. The underlying hypothesis is that peptide bioregulators can reverse or slow aging by re-establishing youthful patterns of protein synthesis in target organs..

Bioregulator Peptides (Khavinson) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.